NCT00002171已完成2 期
A Phase II, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Viracept in Combination With Antiretroviral Therapy in HIV Positive Women With <= 1 Month of Prior Treatment With d4T and/or 3TC
Agouron Pharmaceuticals8 个研究点 分布在 1 个国家开始时间: 2001年8月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 试验地点
- 8
研究概览
简要总结
The purpose of this study is to see if it is safe and effective to give Viracept plus stavudine (d4T) plus lamivudine (3TC) to HIV-positive women with a CD4 count <= 400 cells/mm3. This study also examines how the body handles Viracept when given with d4T and 3TC.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 13 Years 至 —（Child, Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients must have:
- •HIV infection.
- •CD4 T cell count <= 400 cells/mm3.
排除标准
- •Prior Medication:
- •Prior therapy or less than 1 month of therapy with d4T and/or 3TC.
- •Prior protease inhibitor therapy.
研究者
研究点 (8)
Loading locations...
相似试验
已完成
2 期
A Study of Efavirenz in Combination With Stavudine and DidanosineHIV InfectionsNCT00002225Dupont Merck60
已完成
2 期
A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsHIV InfectionsNCT00002227Dupont Merck60
撤回
2 期
Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)Chronic Genotype 1 Hepatitis C Virus InfectionNCT00895882Merck Sharp & Dohme LLC
已完成
3 期
A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia ComplexAIDS Dementia ComplexHIV InfectionsNCT00002246Bristol-Myers Squibb20
已完成
2 期
A Study of Viracept in AIDS Patients With Cytomegalovirus RetinitisCytomegalovirus RetinitisHIV InfectionsNCT00002169Agouron Pharmaceuticals